The Optometry Network has arrived to the market promising to supply some of the most competitively-priced goods and services in Australia. Its founder CONAN LOMAS discusses why it will put independent optometrists first and empower them in the face of corporate competition.
Cataract surgeons are reporting unexpected flow on effects as a result of the pandemic. RHIANNON BOWMAN finds out how they are faring as they return to operating theatres, albeit at reduced capacity with an ever-increasing backlog. Read more
Alcon’s newest EDOF intraocular lens has only been available to a handful of Australian ophthalmologists, but it’s already receiving major plaudits. Could it really change the game for cataract patients and spell the end of monofocals as we know them? MYLES HUME explains.
The days of casually leaning on the reception desk at medical clinics are gone, replaced instead with plastic screens, hand sanitiser and non-contact thermometers. Insight takes a snapshot of the return-to-work landscape as the sector emerges from COVID-19.
How can optometrists pull an elite batsman out of a form slump? What’s the best type of laser vision correction for a boxer? And how are prescription lenses integrated into ski goggles? RHIANNON BOWMAN explores sports vision from three perspectives. Read more
The COVID-19 crisis has spurred a telehealth revolution that’s helping mitigate disruption for practitioners and patients. Leading professionals share their telehealth tips and discuss why the technology might be here to stay. Read more
The great escape for Australia in the COVID-19 battle may have been achieved. At time of writing there were good signs; but only if the next phase is not squandered by political and media discordance. Read more
The 2014 arrival of MIGS to Australia introduced a whole new field of interventional glaucoma therapies. Queensland ophthalmologist Dr Frank Howes re-defines the term and explores current surgical interventions, explaining where each fits in the glaucoma treatment algorithm. Read more
As part of Macula Month this May, Insight explores why treatment adherence remains such a major challenge for some patients and how the sector is working to overcome it. Read more